Literature DB >> 33705258

Nigerian media coverage of medical progress on the development of COVID-19 vaccine.

Chika Euphemia Asogwa1.   

Abstract

There is a global shift in discource on issues related to COVID-19 with greater attention paid to the vaccine. COVID-19. Despite this, the literature on media coverage of COVID-19 is yet to be extended to media coverage of issues related to medical progress on a vaccine for the virus. The objective of the current study was to fill this gap by examining how Nigerian media report COVID-19 vaccine development In doing so, attention was paid to the frequency of coverage, sources of stories as well as story type used. Two newspapers and TV stations were sampled for the current study. The current study made use of content analysis with a code sheet as the instrument for data collection. The result of the current study revealed that only 23% of the media stories on COVID-19 were related to vaccine development. Additionally, most of the stories made use of official sources as well as straight news. Comparatively, newspapers covered more in vaccine development than TV. The implications of these results on medical communication and theory are discussed.

Entities:  

Keywords:  COVID-19; Coverage; Nigeria; TV; cure; newspaper; treatment; vaccine

Mesh:

Substances:

Year:  2021        PMID: 33705258      PMCID: PMC8475581          DOI: 10.1080/21645515.2021.1882282

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  9 in total

1.  Moderna COVID vaccine becomes second to get green light in United States.

Authors:  Heidi Ledford
Journal:  Nature       Date:  2020-12-18       Impact factor: 49.962

2.  Media coverage of chronic diseases in the Netherlands.

Authors:  E M van der Wardt; E Taal; J J Rasker; O Wiegman
Journal:  Semin Arthritis Rheum       Date:  1999-04       Impact factor: 5.532

3.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

4.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

5.  The outbreak of COVID-19: An overview.

Authors:  Yi-Chi Wu; Ching-Sung Chen; Yu-Jiun Chan
Journal:  J Chin Med Assoc       Date:  2020-03       Impact factor: 2.743

Review 6.  Understanding of COVID-19 based on current evidence.

Authors:  Pengfei Sun; Xiaosheng Lu; Chao Xu; Wenjuan Sun; Bo Pan
Journal:  J Med Virol       Date:  2020-03-05       Impact factor: 2.327

7.  How do Nigerian newspapers report COVID-19 pandemic? The implication for awareness and prevention.

Authors:  Oberiri Destiny Apuke; Bahiyah Omar
Journal:  Health Educ Res       Date:  2020-10-01

8.  The media and health education: Did Nigerian media provide sufficient warning messages on coronavirus disease?

Authors:  Verlumun Celestine Gever; Gregory Ezeah
Journal:  Health Educ Res       Date:  2020-10-01

9.  COVID-19 can present with a rash and be mistaken for dengue.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  J Am Acad Dermatol       Date:  2020-03-22       Impact factor: 15.487

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.